Amendment to Schedule 13D for KALA BIO, Inc.

This Amendment No. 1 to Schedule 13D, filed by SR One Capital Fund II Aggregator, LP, SR One Capital Partners II, LP, SR One Capital Management, LLC, and Simeon George, M.D., updates the ownership details of KALA BIO, Inc.'s Common Stock. The amendment reports that Aggregator sold 598,940 shares of Common Stock in open market transactions during the past 60 days. As of October 1, 2025, Aggregator owns 0 shares of Common Stock but has the right to acquire 411,000 shares upon conversion of Series H Preferred Stock. The Reporting Persons collectively hold 5.5% of the outstanding Common Stock. The amendment also includes details on the Reporting Persons' control structure and disclaims beneficial ownership of shares not directly owned. The filing includes exhibits such as a joint filing agreement and a schedule of transactions.